Thromboxane and Prostaglandin Receptor Antagonist
Ifetroban for Treating DMD-Associated Cardiomyopathy
Feb 12, 2020 at 10:06 am by Staff
Cumberland Pharmaceuticals Gears up for Phase II Clinical Trial
Last fall, the U.S. Food and Drug Administration (FDA) announced $15 million in grant funding in support of 12.... Read More